TITLE

Salix Soars on Good Data from Phase III Studies

PUB. DATE
September 2009
SOURCE
Bioworld Week;9/21/2009, Vol. 17 Issue 38, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the positive results of the Phase III studies regarding the use of rifaximin conducted by Salix Pharmaceuticals Ltd. in Raleigh, North Carolina. It states that the trial administered to 600 patients indicate the significant use of the drug in reducing irritable bowel syndrome symptoms. It adds that the group is making more efforts to seek the approval of the U.S. Food and Drug Administration (FDA) for the use of the drug in maintaining hepatic encephalitis remission.
ACCESSION #
44369825

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics